K301 for the Treatment of Seborrhoeic Eczema (SE) of the Scalp

NCT01137331 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

201

Enrollment

INDUSTRY

Sponsor class

Conditions

Seborrhoeic Eczema of the Scalp

Interventions

DRUG: K301
DRUG: Placebo

Sponsor

Moberg Pharma AB